MPM BioImpact portfolio

MPM BioImpact (Venture capital) is known to hold 21 companies, 7 of them startups. 5 of them are hiring now, with 52 open roles. Most of them work in Oncology Therapeutics, Cell & Gene Therapy, Precision Medicine.

Source: Alion Venture capital Oct 10, 2026
Investments
21
7 of them startups
Hiring now
5
52 open roles
Exits
4

Companies MPM BioImpact has invested in

Umoja Biopharma Cell & Gene Therapy · United States Venture round $210M · 5 yr ago 5 roles portfolio pageSep 25
ElevateBio Cell & Gene Therapy Venture round $525M · 5 yr ago 17 roles portfolio pageSep 25
Dyne Therapeutics Prescription Drugs · United States 23 roles portfolio pageSep 25
Entrada Therapeutics Oncology Therapeutics · United States 4 roles portfolio pageSep 25
Frontiermeds Drug Discovery 3 roles portfolio pageSep 25

Focus

Markets
Oncology Therapeutics24%
Cell & Gene Therapy14%
Precision Medicine10%
Custody & Fund Administration5%
Immunology & Inflammation Therapeutics5%
Prescription Drugs5%
Rare Disease Therapeutics5%
Drug Discovery5%
Where its companies are
United States19%
Stage of its companies
Venture, series not stated100%

Questions about MPM BioImpact

How many companies has MPM BioImpact invested in?

MPM BioImpact is known to hold 21 companies: 7 startups, and 4 exits so far, read from its own portfolio page and the funding rounds that name it.

Is MPM BioImpact investing now?

MPM BioImpact has no round in the press in 12 months and no new company on its portfolio page in 90 days.

What does MPM BioImpact invest in?

The markets of the companies MPM BioImpact holds: Oncology Therapeutics (24%), Cell & Gene Therapy (14%), Precision Medicine (10%), Custody & Fund Administration (5%), Immunology & Inflammation Therapeutics (5%).

Which MPM BioImpact portfolio companies are hiring?

5 companies MPM BioImpact holds are hiring now, with 52 open roles listed on this page.

Who does MPM BioImpact invest alongside?

The investors that hold the most companies together with MPM BioImpact: RA Capital Management, EcoR1 Capital, Sofinnova Investments, Wellington Management, DCVC.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Oct 3

MPM BioImpact portfolio: 21 known companies. Alion, Oct 10, 2026. https://alion.io/company/mpm-bioimpact/portfolio

Licence: CC BY-SA 4.0JSON